Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Harpagoside is an iridoid glycoside that has been found in H. procumbens, also known as devil’s claw, and has diverse biological activities.1,2,3 It inhibits LPS-induced increases in COX-2 and nitric oxide (NO) levels, as well as TNF mRNA expression in HepG2 cells when used at concentrations ranging from 50 to 200 µM.1 In vivo, harpagoside (10 mg/kg) reduces synovial inflammation, joint destruction, and bone erosion in a mouse model of collagen-induced arthritis.2 It also decreases substantia nigra pars compacta neuronal cell death and increases time spent on the rod in a rotarod test in a mouse model of MPTP-induced Parkinson’s disease.3
WARNING This product is not for human or veterinary use.
1. Harpagoside suppresses lipopolysaccharide-
2. Harpagoside attenuates local bone erosion and systemic osteoporosis in collagen-
3. Harpagoside attenuates MPTP/MPP⁺ induced dopaminergic neurodegeneration and movement disorder via elevating glial cell line-